Mortgage Marketshare Module
- Accurately track commercial and residential lending, measure sales performance against competition and market activity, identify high-performing competitors, and locate and target emerging markets.
  
  LEARN MORE >>
Loan Originator Module
- Access the largest and most comprehensive mortgage loan origination database in New England with round-the-clock interactive access and weekly trend updates.
  
  LEARN MORE >>
Marketing Lists
- Gain access to the most accurate and detailed transaction information in the country and offers a range of marketing lists for more than 130 million households (covering 94% of the U.S. population).
  
  LEARN MORE >>
Custom Research
- Powered by one-of-a-kind real estate, mortgage, and loan origination data, The Warren Group provides custom solutions for your research projects, database expansion, and strategic planning.
  
  LEARN MORE >>
Real Estate Records Search
- Access the largest and most complete real estate database in New England, including sales, price trends, liens and foreclosures.
  
  LEARN MORE >>

WATCH: Will Boston’s Lab Boom End?

Aug 29, 2022 | Reprints | Print

The numbers are worrisome: 65 percent of life science real estate projects in the planning stages in Greater Boston might be paused or abandoned entirely. And over 1 million square feet of lab space hit the sublease market recently.

But does this actually represent a problem for developers and building owners aiming to cater to the biotech industry? The answer is more nuanced than the topline statistics might make it out to be.

A trio of experts – Liz Berthelette, director of research at brokerage Newmark; Mark Bruso, senior research manager at brokerage JLL New England; and Alex Mancuso, director of leasing for East Coast and U.K. markets at developer BioMed Realty – sat down with Banker & Tradesman associate editor Steve Adams on Aug. 29, 2022 to piece together a picture of what’s happening in the market right now.

B&T Daily